Dear Editor, Tirbanibulin 1% ointment is a topical field therapy approved for actinic keratoses (AKs) of the face and scalp, administered through a concise 5-day regimen with minimal local skin reactions (LSRs)

Tirbanibulin 1% real‐world use in 679 actinic keratoses patients during warm season (SUMM‐AK study)

F. Bellinato;P. Gisondi;
2026-01-01

Abstract

Dear Editor, Tirbanibulin 1% ointment is a topical field therapy approved for actinic keratoses (AKs) of the face and scalp, administered through a concise 5-day regimen with minimal local skin reactions (LSRs)
2026
actinic keratosis
effectiveness
real‐world
safety
tirbanibulin
warm season
File in questo prodotto:
File Dimensione Formato  
JDV-40-e469.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 548.77 kB
Formato Adobe PDF
548.77 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1197712
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact